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Obesity is well known to be a major cause of several chronic metabolic diseases,
which can be partially counteracted by exercise. This is due, in part, to an upregulation
of mitochondrial activity through increased nicotinamide adenine dinucleotide (NAD+).
Recent studies have shown that NAD+ levels can be increased by using the NAD+
precursor, nicotinamide mononucleotide (NMN) leading to the suggestion that NMN
could be a useful intervention in diet related metabolic disorders. In this study we
compared the metabolic, and especially mitochondrial-associated, effects of exercise
and NMN in ameliorating the consequences of high-fat diet (HFD) induced obesity in
mice. Sixty female 5 week old C57BL6/J mice were allocated across five groups: Chow
sedentary: CS; Chow exercise: CEX; HFD sedentary: HS; HFD NMN: HNMN; HFD
exercise: HEX (12/group). After 6 weeks of diet, exercise groups underwent treadmill
exercise (15 m/min for 45 min), 6 days per week for 6 weeks. NMN or vehicle (500 mg/kg
body weight) was injected (i.p.) daily for the last 17 days. No significant alteration in
body weight was observed in response to exercise or NMN. The HFD significantly
altered adiposity, glucose tolerance, plasma insulin, NADH levels and citrate synthase
activity in muscle and liver. HEX and HNMN groups both showed significantly improved
glucose tolerance compared to the HS group. NAD+ levels were increased significantly
both in muscle and liver by NMN whereas exercise increased NAD+ only in muscle.
Both NMN and exercise ameliorated the HFD-induced reduction in liver citrate synthase
activity. However, exercise, but not NMN, ameliorated citrate synthase activity in muscle.
Overall these data suggest that while exercise and NMN-supplementation can induce
similar reversal of the glucose intolerance induced by obesity, they are associated with
tissue-specific effects and differential alterations to mitochondrial function in muscle and
liver.
Keywords: nicotinamide mononucleotide, high fat diet, treadmill exercise, C57BL6 female mice, mitochondria,
liver, muscle
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INTRODUCTION
Obesity is a global health issue with increasing prevalence.
According to the WHO (2015), 1.9 billion adults were overweight
globally in 2014, of which 0.6 billion were obese. In 2014,
The McKinsey Global Institute reported that if the current
growth rate continues, by 2030, almost half of the world’s
adult population will be overweight or obese. The increasing
prevalence of obesity leads to an increased risk of several
other non-communicable diseases including type 2 diabetes,
cardiovascular disease, some cancers, respiratory conditions,
fatty liver disease, reproductive disorders, depression, and other
mental health conditions (Gonçalves et al., 2012; Morris et al.,
2014). Furthermore recent studies on maternal obesity have
revealed the alarming metabolic impact on offspring, including
increased risk for obesity (Borengasser et al., 2014; Catalano,
2015; Raipuria et al., 2015), highlighting the importance of testing
interventions in obese females.
Primarily, the obesity epidemic can be explained as a
result of energy imbalance. Increased energy rich food intake
and/or decreased physical activity result in increased adiposity
(Berthoud et al., 2011; WHO, 2015). Therefore diet is the most
commonly used intervention for obesity. A variety of human
and animal studies have suggested that exercise can exert health
benefits in obesity (Christ et al., 2002; Flores et al., 2006; Vieira
et al., 2009; Ross et al., 2015).
Mitochondria play a vital role in cellular functions such
as regulation of energy metabolism, ATP generation, and
calcium handling. Cellular energy in the form of ATP, is
produced by the interconversion of NAD+ and NADH as a
part of beta oxidation, glycolysis, the TCA cycle and oxidative
phosphorylation. Previous studies have implicated mitochondrial
dysfunction such as decreased mitochondrial numbers, lower
levels of mitochondrial enzymes, and lower ATP synthesis in
muscle and liver as key mechanism mediating obesity-related
diseases such as insulin resistance and type 2 diabetes (Pérez-
Carreras et al., 2003; Lowell and Shulman, 2005; Kim et al.,
2008; Mantena et al., 2008; Jheng et al., 2012; Agil et al., 2015).
Consequently interventions that alter mitochondrial biogenesis
or function have been proposed as an option for combatting
obesity-related disease (Joseph et al., 2011; Holmström et al.,
2012).
Though originally considered a house keeping metabolite
required for redox reactions, NAD+ is now recognized as a
central signaling molecule and enzyme cofactor that is involved
in a variety of fundamental biological processes including energy
metabolism, lifespan regulation, DNA repair, apoptosis, and
telomere maintenance (Belenky et al., 2007). NAD+ levels in
metabolic tissues decrease with age, and also in obesity (Yoshino
et al., 2011; Gomes et al., 2013). However, mouse models
have shown that physical exercise can increase NAD+ levels
in metabolic organs and improve mitochondrial biogenesis and
function (Cantó et al., 2010; Geng et al., 2010; Koltai et al.,
2010). Therefore the beneficial effects of exercise are thought to
be partly mediated through increasing NAD+. Mechanistically,
the Sirtuin class of enzymes are one link between NAD+ and
improved metabolism as they use NAD+ as a cofactor in their
regulation of mitochondrial biogenesis and respiration efficiency,
and metabolism of fats and carbohydrates (Rodgers et al., 2005;
Gerhart-Hines et al., 2007; White and Schenk, 2012).
Nicotinamide mononucleotide (NMN) is a precursor of
NAD+ biosynthesis. Supplementing mice with NMN can
increase NAD+ levels and ameliorate glucose intolerance in
high fat diet (HFD)-induced diabetes, and aged mouse models
(Yoshino et al., 2011; Gomes et al., 2013). Considering that
exercise and NMN supplementation both increase NAD+ levels,
thereby improving metabolism in obese mice, we hypothesized
that NMN would induce similar effects on mitochondrial
biogenesis and function as exercise. We chose to study females,
given the growing obesity rates in women of childbearing age
and the effects of maternal obesity on the next generation (Black
et al., 2013). Specifically, we examined effects of treadmill exercise
and NMN on weight gain, adiposity and glucose tolerance, and
measured mitochondrial copy number, and indices of metabolic




All animal procedures were approved by the Animal Ethics
Committee, UNSW, ethics number 13/25B. Five week old female
C57BL6/J mice (n = 60) were purchased from Animal Resource
Centre, Canning Vale, WA, Australia. Animals were housed (4
mice/cage) at 21◦C ± 2◦C (12:12 h light/dark) at the Biological
Resources Centre facility, UNSW, Australia. Mice were ear
punched 2 days after they arrived. A week later groups of mice
with similar average body weight were assigned to either a control
group (n = 24) that was fed standard rodent chow (11 kJ/g,
maximum crude fat 4% total food weight from Gordon’s Stock
Feeds, Yanderra, NSW, Australia) or an HFD group (n = 36).
The HFD pellets were a semi-pure high fat diet formulation for
laboratory rats and mice based on Research Diets D12451 bought
from Specialty Feeds, Glen Forrest, WA, Australia (contains
23.5% of total weight is fat and 19MJ/kg digestible energy,
Speciality Feeds SF 04-001). Five weeks after dietary intervention
the difference in average body weight between chow and HFD
groups was 23%. The mice were then distributed across five
different groups; again mice were selected so that the average
body weights of the different intervention and control subgroups
were similar. The five groups were: Chow sedentary: CS; Chow
exercise: CEX; HFD sedentary: HS; HFD NMN: HNMN; HFD
exercise: HEX (12/group).
After 4 days of training from the age of 11 weeks, CEX and
HEX mice underwent treadmill running 6 days (45 min/day)
a week for 6 weeks using a Columbus Instruments Exer 3/6
Treadmill (0257-901M). Each session comprised a warm-up
period of running at 3 m/min for 2 min then the speed was
increased gradually to 15 m/min. In each session after 300 m,
mice were rested by running slowly (6 m/min) for 3 min then
returned to 15 m/min for another 20 min. Running of each mouse
was confirmed visually and mice that stopped running by going
on the stationary platform were gently pushed back onto the
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belt with a paper towel. Each exercise session was carried out
an hour before the end of the light phase. All mice in the non-
exercise groups experienced the treadmill with the belt turned off
for 12 min, 5 days a week to control for environmental effects.
NMN (Sigma N3501) was dissolved in PBS and injected i.p. daily
500 mg/kg body weight (Yoshino et al., 2011) for 17 days before
sacrifice. Injection of NMN or vehicle (PBS) occurred daily at the
end of the light phase. Exercised mice were rested a day before
GTT and sacrifice.
Glucose Tolerance Test
At 17 weeks of age animals were weighed and fasted for 5 h
(7 am–12 pm). After the establishment of a baseline glucose level
(Accu-ChekH glucose meter; Roche Diagnostics, Nutley, USA)
mice were challenged with an i.p. glucose bolus (2 g/kg body
weight). Blood glucose concentrations were measured at 15, 30,
60, 90, 120, and 180 min after glucose administration. NMN was
injected 4 h before the glucose injection.
Insulin
During the GTT 5 µl of blood was taken before, 15 min after
and 30 min after glucose injection. Blood was pipetted with
Drummond 5 µl Microcapillary tubes (Sigma–Aldrich) into an
Ultra-Sensitive Mouse Insulin ELISA Kit plate (Crystal Chem
Inc.) and the assay performed using the standard protocol.
Sample Collection and Tissue
Processing
At 18 weeks of age, after 5 h fasting, mice were deeply
anesthetized (ketamine/xylazine 200/20 mg/kg, i.p.). NMN or
vehicle was injected 4 h before anesthetic. The exercise group
had their final session the day before cull. After measurement
of naso-anal (N-A) length, a blood sample was collected by
cardiac puncture. Mice were then sacrificed by decapitation.
Brown adipose tissue (BAT), white adipose tissue (gonadal fat,
retroperitoneal fat, inguinal fat), muscle (quadriceps, tibialis,
soleus) were dissected and weighed, as well as organs (heart,
liver). All tissue was snap frozen using liquid N2 and then
stored at −80◦C. Tissues were ground using a Tissue Pulverizer
(Bessman) on dry ice and liquid N2.
Triglyceride Assay
Ground liver tissue was homogenized in 1.5 ml of a chloroform–
methanol (2:1) mixture using a Precellys 24 homogenizer
(Bertin technologies, France) and transferred in a glass tube.
Another 2.5 ml of chloroform-methanol mixture was added
and samples were mixed for 20–22 h at room temperature on
an electronic roller (BTR10-12V Ratek roller). After rolling,
2 mL of 0.6% NaCl was added; samples were vortexed and
centrifuged (1,000 × g, 10 min, room temperature). The entire
lower phase was transferred in to a new glass tube and evaporated
under nitrogen gas in a heating block at 40◦C for 40 min.
The dried extract was dissolved in 150 µl of absolute ethanol.
The triglyceride concentration was then measured using glycerol
standard (Sigma, St. Louis, MO, USA). Liver triglyceride contents
were determined using a colorimetric assay– TG reagent (Roche
Diagnostics). Two hundred microliters of the reagent added with
10 µl of samples and standards in a 96 well plate. The plate
was then incubated and gently shaken at 37◦C for 6 min before
reading with Bio-Rad iMark plate reader (Bio-Rad, Sydney, NSW,
Australia).
Protein Quantification
Proteins levels were quantified by using a Protein Assay Dye
Reagent Concentrate (Bio-Rad). A prediluted Protein Assay
standard Bovine Serum Albumin (BSA) set (Thermo Scientific)
was used to make the standard curve.
Citrate Synthase Assay
The assay was carried out according to the method described
by Turner et al. (2007). Briefly, powdered tissue samples were
homogenized 1:19 (wt/vol) in 50 mmol/l Tris-HCl, 1 mmol/l
EDTA, and 0.1% Triton X-100, pH 7.2, using a polytron
homogenizer (IKA T 10 Basic ultra-turrax, VWR instruments Pty
Ltd) and were subjected to three freeze-thaw cycles with liquid
N2. Citrate synthase, was determined at 30◦C, using a Bio-Rad
Imark microplate reader. Enzyme activities are presented as units
per mg of protein, where units are defined as micromoles per
minute.
NAD+ Assay
Levels of NAD+ and its reduced form NADH were measured as
previously described with modifications (Zhu and Rand, 2012).
First, samples were homogenized in extraction buffer (10 mmol/l
Tris/HCl, 0.5% Triton X-100, 10 mmol/l Nicotinamide, pH 7.4)
and then centrifuged (12,000× g for 5 min at 4◦C), after which an
aliquot of supernatant was taken for protein quantification. After
phenol:chloroform: isoamyl alcohol (25:24:1) and chloroform
extractions the supernatant was separated in two aliquots. One
was used to measure total NAD. The other aliquot was acidified
with HCl then neutralized with NaOH on ice to quantify
NAD+. On a 96 well plate samples were mixed with alcohol
dehydrogenase (ADH) in separate wells at room temperature.
Total NADH and NAD+ were quantified using a Bio-Rad Imark
microplate reader; data are presented as pmol of NAD+ or
NADH per mg of protein.
Western Blot
Protein was extracted as described previously Brandon
et al. (2015). Approximately 30 mg of powdered tissue was
homogenized in RIPA buffer (65 mmol/l Tris (pH 7.4),
150 mmol/l NaCl, 5 mmol/l EDTA, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS, 10% glycerol, 1 µg/ml
aprotinin, 1 µg/ml leupeptin, 10 mmol/l sodium fluoride,
1 mmol/l sodium vanadate, 1 mmol/l PMSF, and 50 mmol/l
nicotinamide) using a Precellys 24 (Bertin Technologies). After
lysis and homogenization the samples were incubated (4◦C) for
2–3 h, then centrifuged at 12,000 × g to remove any insoluble
particles and protein concentration was determined.
Clarified lysates were then diluted with 2X Laemmli buffer and
heated to 65◦C for 15 min. BLUeye Prestained Protein Ladder
was used as molecular weight ladder. Equal amounts of protein
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(20 ug/well) were electrophoresed through a 4–15% precast gel
(Criterion TGX, Bio-Rad) for 45 min at 150 V in running buffer
(25 mmol/l Tris base, 192 mmol/l glycine, and 1% SDS, pH 8.3).
Proteins were transferred via a semi dry transfer process with
a Trans Blot Turbo System (Bio-Rad) onto PVDF membranes
(Bio-Rad). Membranes were then blocked in 4% BSA in TBS-
Tween for 1 h, then incubated overnight at 4◦C with primary
antibodies used at 1:1000 dilution; Mitoprofile total OXPHOS
rodent antibody cocktail (MitoScience); PGC-1α (3G6) Rabbit
mAb (Cell Signaling). The membrane was subjected to three
10 min washes with TBS-Tween, and incubation with appropriate
secondary antibody (Cell Signaling) in 2% skim milk blocking
solution in TBS-Tween at room temperature for 1 h, followed
by three 10 min washes with TBS-Tween. For detecting bands,
membranes were exposed to Clarity Western ECL Substrate (Bio-
Rad) and visualized on a Bio-Rad ChemiDoc XRS. Membranes
were stripped using Reblot Plus (10X) (Millipore) for 10 min at
room temperature. Membranes were re-blocked and overnight at
4◦C with GAPDH antibody (14C10) Rabbit mAb (Cell Signaling).
The subsequent steps with this housekeeper blot were the same as
described above for the OXPHOS cocktail and PGC-1α blots.
Mitochondrial DNA Copy Number
Mitochondrial DNA copy number was measured by qPCR. DNA
was extracted from muscle and liver. For this, 25–30 mg of tissue
was subjected to lysis overnight (10 mmol/l Tris, 100 mmol/l
NaCl, 10 mmol/l EDTA, 0.5% SDS pH8), containing proteinase
K (1 µg/ul). The lysate was then mixed with phenol:chloroform
and DNA extracted. Spectrophotometric quantification using
Biospec-nano spectrophotometer (Shimadzu Biotech, Nakagyo-
ku, Kyoto, Japan) determined DNA concentration and purity.
A SYBR green Qpcr (SensiFAST SYBR, Bioline) was used to
determine mitochondrial DNA copy number. Two primers
were used, 36B4 (F = ACTGGTCTAGGACCCGAGAAG;
R = TCAATGGTGCCTCTGGAGATT) for the nuclear
genome (amplifies a region of the Rplp0 gene) and Cytb
(F = CCCACCCCATATTAAACCCG; R = GAGGTATGAA
GGAAAGGTATTAGGG) for the mitochondrial genome. Cytb
and 36B4 levels were quantified with Roche LightCycler480
software, whereby standard curves were produced for each gene
using templates generated by serial dilution of a sample made by
combining an aliquot of DNA from each of the 60 samples. All
sample PCRs were done in duplicate, normalization was done by
dividing Cytb by 36B4.
Quantitative RT-PCR
By using Tri-reagent (Sigma, St. Louis, MO, USA), RNA was
extracted from 30 to 32 mg of tissue and stored at −80◦C.
RNA concentration and purity was determined (Biospec-nano
spectrophotometer Shimadzu Biotech, Nakagyo-ku, Kyoto,
Japan). One microgram of RNA was treated with DNase I
Amplification Grade (Invitrogen; Cat# 18068015) and reverse
transcribed to cDNA using an Omniscript Reverse Transcription
kit (Qiagen, Valencia, CA, USA) following manufacturer’s
instructions, and stored at −30◦C. Expression of the following
target genes: Sirt1 (F=TGTGAAGTTACTGCAGGAGTGTAAA;
R = GCATAGATACCGTCTCTTGATCTGAA), Sirt3 (F =
GGTTGAAGCTTATGGA, R = AGGTTTTGAGGCAGGGA),
PGC-1a (F = TATGGAGTGACATAGAGTGTGCT, R = CC
ACTTCAATCCACCCAGAAAG), Cytb (Same primers as
used for mtDNA copy number) was measured using the
Roche LightCycler480. Standard curves were produced for
each gene using templates generated by serial dilution of a
combined cDNA sample from each of the 60 samples. All
sample PCRs were done in duplicate, and all genes of interest
were normalized by dividing by the geometric mean of two
control genes Gapdh (F = AGGTCGGTGTGAACGGATTTG,
R = TGTAGACCATGTAGTTGAGGT) and Ywhaz (F = GAA
AATGAAGGGTGACTACTAC, R = CTGATTTCAAATGCTT
CTTG) which had been determined with Normfinder software
(MOMA) to be the most stable of 4 tested control genes (Hprt
and Tbp being the other genes). No difference in expression of
housekeeper genes was observed across treatment groups.
Statistical Analysis
Results are expressed as mean ± SEM. All data were analyzed
using one-way ANOVA, followed by post hoc LSD tests using
SPSS. If data were not normally distributed they were log
transformed to achieve normality before they were analyzed.
Different superscripts represent significant differences between
the designated groups (∗Diet Effect; XExercise effect; ∧NMN
effect). Significance levels are indicated; ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p< 0.001.
RESULTS
High Fat Diet and Interventions Impacted
Body Weight and Tissue Mass
At 5 weeks of age, before separating the mice onto different diets
(Chow or HFD), average body weight was 16.63± 0.12 g. A week
later the mice selected for chow and HFD fed groups weighed
16.83 ± 0.81, and 16.71 ± 0.89 g, respectively. After 6 weeks of
the diet, and before the exercise intervention started HFD fed
animals were 23% heavier than chow-fed animals (21.94± 1.98 g
vs. 17.90 ± 0.76 g). Increased weight gain by HFD fed animals
continued until the end of the experiment (Figure 1; Table 1). We
observed a slight (non-significant) reduction of the body weights
of the exercised and NMN-treated mice (Table 1). There were
no differences in tissue weights between the CS and CEX groups,
either as net values or after correction for body weight. However,
dissected fat pads, muscles and liver were significantly higher in
HFD sedentary animals compared to those consuming chow. In
those consuming HFD, both NMN and exercise interventions
reduced net liver mass (Table 1) but this difference did not remain
after correction for body weight. In the HEX group, exercise
reduced net fat pad and liver mass compared to HS, and this
was maintained for gonadal and inguinal pads when standardized
by body weight. (Table 1). Quantitation of liver triglyceride
revealed that the HFD increased liver triglyceride content by
approximately 50%, and both exercise and NMN treatment
significantly reduced liver triglyceride in the HFD-fed groups
to around 20% above the level seen in mice consuming control
diet (CS; Figure 2). This demonstrates that both interventions
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FIGURE 1 | Body weight of Chow sedentary (CS), Chow exercise (CEX),
HFD sedentary (HS), HFD NMN (HNMN), and HFD exercise (HEX) mice
over the experiment. Data are shown as mean ± SEM (n = 11–12/group).
Data were analyzed by one way ANOVA followed by LSD post hoc test.
∗∗P < 0.01, ∗∗∗P < 0.001 significant difference HS compared to CS.
partially reversed the HFD-induced increases in liver triglyceride
content. Exercise had no significant impact in chow fed mice
(Figure 2).
NMN Supplementation and Exercise
Improved Glucose Tolerance in HFD Fed
Mice
Glucose tolerance test results shown in Figure 3 demonstrate that
both interventions improved HFD-induced glucose intolerance.
The basal glucose concentration and time taken to clear injected
glucose was significantly higher in HFD sedentary animals
compared to chow fed animals (Figure 3A). The HEX and
HNMN groups had reductions in plasma glucose concentration
compared to HS from 15 min after glucose injection until
FIGURE 2 | Liver triglyceride (mg/g of tissue) of CS, CEX, HS, HNMN,
and HEX mice. Data are shown as mean ± SEM (n = 9–11/group). Data
were analyzed by one way ANOVA followed by LSD post hoc test. ∗∗P < 0.01
significant difference HS compared to CS. ∧∧∧P < 0.001 significant difference
HNMN compared to HS. XXXP < 0.001 significant difference HEX compared
to HS.
180 min. However, there was no difference in the GTT between
the CS and CEX groups. The beneficial effects of NMN and
exercise in increasing the rate of glucose clearance from the
blood of obese mice were also significant when the area under
the curve was assessed (Figure 3B, both P < 0.01). To test
insulin concentrations under fasting conditions or after a glucose
bolus we measured plasma insulin during the GTT. High fat
diet fed animals showed significantly higher plasma insulin
concentrations than chow fed animals; neither exercise nor the
NMN intervention had any impact on insulin concentrations
during the GTT (Supplementary Figure S1). This may suggest
that the insulin peak occurred prior to the 15 min time-
point.
TABLE 1 | Dissected tissue weight and % body weight of Chow sedentary (CS), Chow exercise (CEX), HFD sedentary (HS), HFD NMN (HNMN), and HFD
exercise (HEX) mice.
CS CEX HS HNMN HEX
Final body weight (g) 19.5 ± 0.1 18.9 ± 0.3 28.2 ± 1.4∗∗∗ 25.9 ± 1.3 25.6 ± 0.8xxx
Liver (mg) 726.7 ± 39.0 753.3 ± 44.5 855.4 ± 35.8∗ 717.7 ± 26.3∧∧ 755.7 ± 25.03x
Muscle (mg) Quad 274.4 ± 5.3 277.5 ± 6.7 310.3 ± 6.3∗∗∗ 317.8 ± 9.2 328.6 ± 7.6
AT 81.25 ± 4.09 80.25 ± 2.96 81.25 ± 3.34 89.583 ± 2.21 90.08 ± 3.89
Soleus 13.92 ± 0.36 13.42 ± 0.40 16.33 ± 0.53∗∗ 15.50 ± 0.71 17.17 ± 0.55
WAT (mg) Gonadal 150.5 ± 8.2 167.8 ± 11.2 1166.5 ± 172.4∗∗∗ 909.8 ± 157.5 754.3 ± 70.9xx
Inguinal 156.5 ± 6.4 165.3 ± 12.1 728.25 ± 91.6∗∗∗ 580.4 ± 86.6 530.2 ± 44.5x
RP 30.50 ± 2.06 32.83 ± 2.86 268.00 ± 49.04∗∗∗ 202.92 ± 32.33 186.33 ± 19.84x
Liver % BW 3.73 ± 0.20 3.98 ± 0.22 3.07 ± 0.12∗∗ 2.82 ± 0.14 2.98 ± 0.14
Muscle % BW Quad 1.41 ± 0.03 1.48 ± 0.04 1.12 ± 0.07∗∗∗ 1.25 ± 0.05 1.29 ± 0.04
AT 0.42 ± 0.02 0.43 ± 0.02 0.29 ± 0.02∗∗∗ 0.36 ± 0.02 0.35 ± 0.01x
Soleus 0.07 ± 0.001 0.07 ± 0.002 0.06 ± 0.003∗∗ 0.06 ± 0.002 0.07 ± 0.002
WAT % BW Gonadal 0.77 ± 0.04 0.89 ± 0.05 3.92 ± 0.47∗∗∗ 3.27 ± 0.43 2.92 ± 0.19xxx
Inguinal 0.80 ± 0.03 0.87 ± 0.06 2.49 ± 0.23∗∗∗ 2.12 ± 0.23 2.04 ± 0.12xxx
RP 0.16 ± 0.01 0.17 ± 0.01 0.89 ± 0.13∗∗∗ 0.74 ± 0.08 0.71 ± 0.06xxx
Data are shown as mean ± SEM (n = 9–11/group). Data were analyzed by one way ANOVA followed by LSD post hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
significant difference HS compared to CS. ∧∧P < 0.01 significant difference HNMN compared to HS. XP < 0.05, XXP < 0.01, XXXP < 0.001 significant difference HEX
compared to HS.
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FIGURE 3 | Glucose tolerance test (A, mmol/l) in CS (open circle) CEX (open triangle), HS (closed circle), HEX (closed triangle) and HNMN (closed
square) mice, and (B) Area under the curve (mmol/l min). Data are shown as mean ± SEM (n = 11–12/group). Data were analyzed by one way ANOVA
followed by LSD post hoc test. ∗∗∗P < 0.001 significant difference HS compared to CS. ∧∧P < 0.01, ∧∧∧P < 0.001 significant difference HNMN compared to HS.
XP < 0.05, XXP < 0.01, XXXP < 0.001 significant difference HEX compared to HS.
NAD+ and NADH Levels Are Altered by
HFD but Effects of Interventions Are
Tissue Specific
NAD+ levels were measured in both muscle and liver. Previously
it was shown that 7 days of NMN injection increased NAD+
levels in livers of diabetic mice (Yoshino et al., 2011), and exercise
increased NAD+ in rodent skeletal muscle (Cantó et al., 2010;
Koltai et al., 2010). In our experiment there was a trend for
a reduction in NAD+ by HFD but a significant increase by
NMN injection in both tissues, with the greatest increase in
liver (Figures 4A,B). Exercise also increased NAD+ levels in
muscle but not in liver compared to the HFD sedentary group. In
muscle and liver, NADH was significantly increased by HFD in
both tissues, and this was ameliorated by exercise in both tissues
(significantly in muscle; Figures 4C,D). In liver the HNMN
group had a further significant increase of NADH (Figure 4D),
possibly due to the extremely high levels of reduced and oxidized
NAD in the tissue.
Citrate Synthase Activity Was Reduced
by HFD but Increased by Interventions in
a Tissue-Specific Manner
We measured citrate synthase activity in both muscle and liver
(Figures 5A,B). In muscle, HFD consumption led to a reduction
in citrate synthase activity, which was ameliorated by exercise but
not by NMN. In liver, there was also a trend for reduced citrate
synthase activity due to HFD associated obesity (P = 0.086) but
both exercise and NMN led to significant increases relative to the
HFD vehicle group (Figure 5B, both P < 0.001).
Tissue-Specific Effects of NMN
Supplementation on Mitochondrial DNA
Copy Number
To investigate mitochondrial biogenesis, we measured
mitochondrial DNA (mtDNA) copy number in muscle and
liver (Figures 5C,D). Consumption of HFD significantly
increased copy number in liver, and there was a similar trend
in muscle (P = 0.087). There were contrasting effects of NMN
treatment in muscle and liver of the HFD mice as mtDNA copy
number was increased in the former and decreased in the latter.
OXPHOS Proteins and mRNA Levels of
Mitochondria Associated Genes
Five different complexes are involved in oxidative
phosphorylation in the mitochondria (Huss and Kelly, 2005).
We measured the total levels of a representative protein from
complexes I, II, III, and V. In muscle we found no changes in
proteins from complexes I, II, and V due to HFD or the two
interventions. However, complex I and II proteins were increased
in CEX compared to CS mice (Supplementary Figure S2). In
liver, there were no diet-induced changes in complexes I, II,
III, and V. However, exercise in obese mice decreased the levels
of complexes II and III proteins (Supplementary Figure S2).
PGC-1α is a master regulator of mitochondrial function and
biogenesis. However, we did not detect any differences in
total level of the protein between groups (Supplementary
Figure S2).
We also assayed mRNA levels of genes that are responsible
for mitochondrial biogenesis, mitochondrial content and
function. No HFD or exercise or NMN intervention-induced
transcriptional changes were seen in Sirt1, Sirt3, PGC-1α or Cytb
(Supplementary Figure S3).
DISCUSSION
There is much current interest in evaluating the utility of drugs
that increase NAD+ levels. These drugs include resveratrol (Baur
et al., 2006; Lagouge et al., 2006; Timmers et al., 2011) NMN
(Yoshino et al., 2011; Canto and Auwerx, 2012) and nicotinamide
riboside (NR; Canto and Auwerx, 2012; Gariani et al., 2016). Here
we compared the effects of NMN and exercise in the context
of dietary obesity. Our study comprised a relatively short i.p.
administration of NMN (17 days), once obesity was established in
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FIGURE 4 | NAD+ (A) and NADH (B) content (pmol/mg protein) of quadriceps muscle and liver (C,D) of CS, CEX, HS, HNMN, and HEX mice. Data are
shown as mean ± SEM (n = 6–8/group). Data were analyzed by one way ANOVA followed by LSD post hoc test. ∗P < 0.05, ∗∗P < 0.01 significant difference HS
compared to CS. ∧∧∧P < 0.001 significant difference HNMN compared to HS. XP < 0.05 significant difference HEX compared to HS.
the mouse, and like the exercise intervention we designed, it did
not have a significant effect on body weight. Yoshino et al. (2011),
also reported no body weight changes in their 7–10 days NMN
treatment of HFD-fed mice (Yoshino et al., 2011). We predict
that longer term NMN supplementation would reduce body
weight in mice as this was observed with longer term (beyond
7 weeks) food supplementation of NR (Canto and Auwerx, 2012;
Gariani et al., 2016) or resveratrol (Baur et al., 2006; Lagouge
et al., 2006). The exercise intervention chosen for our study
was a relatively mild regime. However, both NMN and exercise
induced considerable physiological and metabolic changes that
are consistent with amelioration of obesity-related phenotypes.
Furthermore the outcomes give insight into the primary effects
of NMN supplementation as opposed to secondary benefits such
as those caused by weight loss. Finally, our study is the first in the
area of NAD+ therapy to perform a head-to-head comparison of
an NAD+-increasing drug and exercise. Interesting differences
emerged between these two interventions when we examined
the underlying markers of mitochondrial biology in muscle and
liver.
Many studies have described changes in mitochondrial
parameters due to HFD-induced obesity (Koves et al., 2008;
Begriche et al., 2013). However, the extent and even direction
(increases or decreases) of those changes vary. This variation
is due to a multitude of factors such as differences in
the organism, tissue type, formulation of diet, length of
diet, level of tissue adiposity/inflammation, and intensity
of exercise. In general, muscle responds to a HFD by
increasing mitochondrial content, and thereby its capacity
to catabolise fats. However, the mitochondria can have
compromised function due to overload which is thought to
be induced by excessive beta-oxidation (Koves et al., 2008).
In severe fatty liver disease liver mitochondrial function
is reduced through a variety of mechanisms reviewed in
Begriche et al. (2013). However, in fatty livers without cirrhosis
mitochondrial biogenesis and function may be increased or
decreased. Variation in the factors listed above is thought
to be responsible for this inconsistency (Begriche et al.,
2013).
Exercise increases the rates of lipolysis and fat oxidation
(Turner et al., 2014) and accordingly exercise training in
obese rodents has been shown to increase lipid metabolism
and mitochondrial biogenesis in muscle (Suga et al.,
2013; Kwon et al., 2014). Fewer studies have examined
liver mitochondria in exercise trained rodents. Exercise
training in non-obese rodents has been shown to increase
mitochondrial respiration (Sun et al., 2010; Fletcher et al.,
2014) but both increases (Sun et al., 2010) and decreases
(Lu et al., 2013) in mitochondrial biogenesis have been
reported.
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FIGURE 5 | Citrate synthase (µ mol/mg protein) and mtDNA copy (arbitrary number) in quadriceps muscle (A,C) and liver (B,D) of CS, CEX, HS,
HNMN, and HEX mice. Data are shown as mean ± SEM (n = 9–11/group). Data were analyzed by one way ANOVA followed by LSD post hoc test. ∗∗P < 0.01,
∗∗∗P < 0.001 significant difference HS compared to CS. ∧∧P < 0.01, ∧∧∧P < 0.001 significant difference HNMN compared to HS. XXXP < 0.001 significant
difference HEX compared to HS.
As expected, obesity impacted the levels of NAD+ and NADH
in the muscle and liver. The increase in NADH in both of these
tissues is indicative of a diminished ability of the mitochondria to
generate ATP. NMN supplementation increased NAD+ levels to
a greater degree in liver than muscle, suggesting a greater impact
of NMN supplementation in the liver.
In muscle from obese mice, exercise increased NAD+, and
decreased its reduced form, NADH, suggesting an improvement
of cellular oxidative capacity. However, in NMN-supplemented
mice the concomitant high levels of NAD+ and NADH may
be an indicator of high levels of reduction of NAD+ to
NADH. The significant decrease in liver mass and triglyceride
content, and increased CS activity of HFD-fed mice following
NMN-supplementation suggest another aspect of the NMN
intervention is likely to be increased catabolism of fats.
Despite the large impact on markers of mitochondrial function
and fat deposition in the livers of NMN-supplemented obese
mice, other mitochondrial markers were less affected. Compared
to the HS group mtDNA copy number was slightly decreased in
HNMN livers and no changes were detected in the abundance
of proteins involved in oxidative phosphorylation. Canto and
Auwerx (2012) and Gariani et al. (2016) observed that long-
term NR-supplementation also decreased liver weight, liver
fat content, increased NAD+ levels and CS activity. However,
unlike our study they also reported an increase in mtDNA
and OXPHOS complex V (ATP Synthase). This suggests that
a major clinical feature of NAD+-increasing drugs, namely
reduction of liver fat, does not require an increase in mtDNA
and OXPHOS components. If this is the case, then the NAD+-
stimulated fat metabolism pathways (Han et al., 2010; Ponugoti
et al., 2010) may be more clinically important than NAD+-
stimulated mitochondrial biogenesis (Wu et al., 1999; Nemoto
et al., 2004) pathways in liver. However, we cannot rule out
the possibility that species differences, the type of NAD+
precursor, or mode of delivery may also account for this
discrepancy.
In contrast to liver, muscle NMN supplementation was
associated with an increase in mtDNA, though no changes were
seen in CS activity or OXPHOS protein levels. Canto et al.,
(Canto and Auwerx, 2012) also reported increased mtDNA in
quadriceps with long-term NR supplementation (incidentally
also with no changes to Sirt1 or PGC-1α transcript levels),
however, they also observed increases in OXPHOS complex
V. These results suggest that NAD+-increasing drugs have
different effects on the muscle from the liver. More specifically,
that mitochondrial DNA content is more stimulated in the
muscle than the liver. The absence of an OXPHOS complex
V increase in our model may be due to the short-term of
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intervention or again due to differences in drug-type or delivery
across studies. Other markers of mitochondrial function such as
substrate utilization would have been useful to investigate this
further.
The exercise intervention had a greater impact on the HFD
fed mice than the control diet group, the CEX mice were
similar to the CS group across many parameters. For example
there were no differences between CS and CEX in body or
organ weights, GTT, NAD+, or NADH levels, CS activity or
mtDNA. The only differences were an increase in OXPHOS
complex I and II proteins in the muscle of the CEX group.
This small difference is likely due to the exercise intervention
being relatively mild, and both groups being young healthy
mice. The intervention did however, have a considerable impact
in the HFD group (HEX) compared to the HFD sedentary
group (HS). Although there was no significant difference in
body weight, white adipose tissue weights were reduced. Other
measurements such as GTT, liver weights and liver triglyceride
levels were improved in HEX to very similar levels as in the
HNMN intervention group. This similarity increases the value of
the comparison between the two interventions as, for example,
we can contrast the mitochondrial parameters in the livers of
the two groups that ultimately resulted in similar reduction
in triglyceride levels compared to the HS group (discussed
below).
In quadriceps muscle the HEX groups showed effects that
were consistent with long-term exercise (Brandauer et al., 2013;
Yuan et al., 2014). More NAD+ was produced, presumably
through increased catabolism of fat and carbohydrates
resulting in oxidation of NADH. This is supported by the
increase in CS activity in HEX vs. HS muscle. The NAD+
and NADH changes in the HEX and HNMN groups
were similar (though NADH reduction in HNMN was
not significant) which suggests that in that regard NMN-
supplementation does mimic exercise. However, CS activity
was increased by exercise but not NMN which points to
some underlying differences in mitochondrial function.
Mitochondrial biogenesis may also differ in muscle between the
two interventions as exercise did not increase mtDNA, while
NMN did.
The exercise effects in liver in the HEX compared to
the HS group were consistent with those seen with long-
term exercise (Goncalves et al., 2013). The largest difference
between the two interventions in the liver was in the level
of NAD+ and NADH, as NMN-supplementation increased
them considerably, while exercise did not. This is in stark
contrast to the similarities in triglyceride content, CS activity
and mtDNA copy number. Investigation of this difference is
likely to be central to future work that aims to explain how liver
mitochondrial biology is differentially regulated by exercise and
NAD+-increasing drugs. For example NMN-supplementation
may stimulate mitochondrial function though saturating the cell
with an oxidizing agent (NAD+), or through stimulating sirtuin
mediated pathways (Kim ref), while the effects of exercise on liver
mitochondria may be more regulated by signalzing from muscles
or the brain (Lima et al., 2013).
CONCLUSION
In summary, in our study both exercise and NMN were
shown to partly ameliorate the pathophysiology of HFD-induced
obesity in female mice. However, the two interventions have
tissue-specific differences in their alteration of mitochondrial
biogenesis and function. These differences have implications for
the potential use of NMN for the treatment of obesity or fatty
liver. Given that NMN treatment resulted in greater changes in
markers of mitochondrial function in liver than muscle, NAD
precursor-based therapies may be more effective for treatment of
obesity-associated liver diseases such as non-alcoholic fatty liver
disease.
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FIGURE S1 | Insulin concentrations during GTT of Chow sedentary (CS),
Chow exercise (CEX), HFD sedentary (HS), HFD NMN (HNMN), and HFD
exercise (HEX) mice, expressed relative to CS concentration at time 0.
Data are shown as mean ± SEM (n = 11–12/group) and are expressed relative to
CS at baseline. Data were analysed by one way ANOVA followed by LSD post hoc
test. ∗∗P < 0.01, ∗∗∗P < 0.001 significant difference HS compared to CS.
FIGURE S2 | Mitochondrial complexes (I, II, V) in muscle (A–C), PGC-1a
protein levels in muscle (D) and Mitochondrial complexes (I, II, III, V) in
liver (E–H) of CS, CEX, HS, HNMN, and HEX mice. Data are shown as
mean ± SEM (n = 7–8/group). Data were analyzed by one way ANOVA followed
by LSD post hoc test. ∗P < 0.05, ∗∗P < 0.01. Significant difference HS compared
to CS; XP < 0.05 significant difference HEX compared to HS.
FIGURE S3 | mRNA expression of targeted genes in muscle Sirt1 (A), Sirt3
(B), PGC-1a (C), and CYTB (D) of CS, CEX, HS, HNMN, and HEX mice. Data
are shown as mean ± SEM (n = 8–11/group). Data were analyzed by one way
ANOVA followed by LSD post hoc test.
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